The ‘’Super Green Pathway’’; What Have We Learned So Far? The experience and outcomes of elective urgent and cancer surgery in a District General Hospital in the United Kingdom during Covid-19 Pandemic.
Article Sidebar
Main Article Content
Abstract
Background
The coronavirus disease (COVID-19) had so far claimed more than 600 000 lives worldwide. Many urgent and elective surgeries were postponed to cope with the pandemic, with the latest data found a substantial postoperative mortality risk (25.6%, 18.9%) after an emergency and elective surgery, respectively. Our institution was one of the first few in the country to offer essential elective surgery using a “COVID-free” designated site during the start of the pandemic. This study aims to analyze the clinical outcomes of patients who underwent essential elective procedures during the virus outbreak in the UK.
Methods
Retrospective analysis of outcomes of all patients who had undergone urgent elective and cancer surgery, from 30th March 2020 to 21st May 2020, using an implemented “Super Green Pathway.”
The primary endpoints were 30 days mortality and COVID-related morbidities, and the secondary end-points were surgically related complications and oncological outcomes.
Results
A total of 92 patients (Male: 45%; Female: 55%) across 5 surgical specialties were identified. There was no record of mortality in our cohort. Only 1 patient was tested positive for SARS-CoV-2, 18 days after the initial operation without any pulmonary complications. There were 7 postoperative surgical complications managed at the acute hospital site. The waiting time for surgery ranges from 6 to 191 days, mean of 30 days, and a median of 23 days.
Conclusion
It is possible to mitigate the high mortality risk of post-operative complications associated with COVID-19, with no delay to essential surgeries for cancer patients, thus delivering safe practice during the pandemic.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.
References
2. World Health Organization. [Internet] Naming the Coronavirus Disease (COVID-19) and the Virus that Causes it. Geneva: World Health Organization; 2020. Available at: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.2020 Feb 15;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
4. World Health Organization. [Internet] WHO Timeline COVID-19. Geneva: World Health Organization; 2020. Available at: https://www.who.int/news-room/ detail/29-06-2020-covidtimeline
5. GOV.UK N. West, and S. West. [Internet] Number of Coronavirus (COVID-19) Cases and Risk. London: GOV.UK; 2020.
6. GOV.UK. [Internet] Prime Minister’s Statement on Coronavirus. London: GOV.UK; March, 2020. Avail-able at: https://www.gov.uk/government/speeches/ pm-statement-on-coronavirus-12-march-2020
7. Royal College of Surgeons. [Internet] Guidance for surgeons working during the COVID-19 pandemic from the Surgical Royal Colleges of the United Kingdom and Ireland. London: RCS; 2020. https://www.rcseng.ac.uk/ coronavirus/joint-guidance-for-surgeons-v1/
8. Federation of Surgical Specialty Association. Clinical Guide to Surgical Prioritisation During the Coronavirus Pandemic. Glasgow, UK: FSSA; 2020. Available at: https://fssa.org.uk/_userfiles/pages/files/covid19/ prioritisation_master_240820.pdf
9. Public Health England. [Internet] Guidance on Shielding and Protecting People Who Are Clinically Extremely Vulnerable from COVID-19. London: GOV.UK; 2020. Available at: https://www.gov.uk/government/publications/ guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19
10. Iksal M. No 主観的健康感を中心とした在宅高齢者 における 健康関連指標に関する共分散構造分析 Title 2020;21(1)1–9.
11. Goddard B. Nuffield being used to support cancer patients during pandemic. Hereford Times April 2020. Available at: https://www.herefordtimes.com/news/18389997.nuffield-used-support-cancer-patients-pandemic/
12. Brennan S. Trusts told to create ‘covid-free hubs’ for cancer patients. HSJ April 2020; Available at: https:// www.hsj.co.uk/acute-care/trusts-told-to-create-covid-free-hubs-for-cancer-patients/7027306.article
13. Royal College of Surgeons of Edinburgh (RCSEd). [Internet] Updated General Surgery Guidance on COVID-19, 2nd Revision. Edinburgh, UK: RCSEd; May 2020. Available at: https://www.rcsed.ac.uk/news-public-affairs/news/2020/april/updated-general-surgery-guidance-on-covid-19-2nd-revision-7th-april-2020
14. National Health Service. Operating Framework for Ur-gent and Planned Services in Hospital Settings During COVID-19. London: May, 2020. Available at: https:// www.england.nhs.uk/coronavirus/wp-content/uploads/ sites/52/2020/05/Operating-framework-for-urgent-and-planned-services-within-hospitals.pdf